Skip to main content
. 2019 Jan 29;51(4):1324–1335. doi: 10.4143/crt.2018.653

Table 3.

Univariate and multivariate competing risk analyses of vertebral compression fracture after SRS in spinal metastasis

Characteristic No. of regions No. of events (%) Univariatea)
Multivariateb)
SHR 95% CI p-value SHR 95% CI p-value
Age (yr)
 ≤ 55 50 2 (4) Reference Reference
 > 55 99 9 (9) 2.616 0.586-11.684 0.208 1.595 0.268-9.479 0.608
Sex
 Male 90 9 (10) Reference
 Female 59 2 (3) 0.344 0.074-1.605 0.175 NA
ECOG performance status
 0-1 137 9 (7) Reference
 2-4 12 2 (17) 2.902 0.617-13.649 0.177 NA
Primary tumor
 Lung 32 1 (3) Reference Reference
 Breast 25 0 0.000 NA < 0.001 0.000 NA <0.001
 HCC 33 4 (12) 4.029 0.456-35.608 0.210 4.369 0.372-51.299 0.241
 RCC 10 1 (10) 3.619 0.233-56.192 0.358 2.585 0.095-70.547 0.573
 Others 49 5 (10) 3.548 0.427-29.471 0.241 4.111 0.470-35.958 0.201
Solitary metastasis
 No 129 10 (8) Reference
 Yes 20 1 (5) 0.619 0.078-4.910 0.649 NA
SINS criteria
 Tumor location
  Junctional (occiput-C2, C7-T2, T11-L1, L5-S1) 58 5 (9) Reference
  Mobile spine (C3-C6, L2-L4) 44 3 (7) 0.791 0.190-3.293 0.747 NA
  Semi-rigid (T3-T10) 47 3 (6) 0.775 0.184-3.269 0.728
 Pain
  Pain-free lesion 38 1 (3) Reference Reference
  Occasional pain but not mechanical 78 7 (9) 3.829 0.475-30.813 0.207 11.769 0.866-159.715 0.064
  Mechanical 33 3 (8) 4.035 0.418-38.937 0.228 5.370 0.518-55.718 0.159
 Bone lesion quality
  Lytic 102 8 (8) Reference Reference
  Mixed (lytic/blastic) 30 2 (7) 0.923 0.191-4.464 0.921 0.769 0.099-5.970 0.801
  Blastic 17 1 (6) 0.615 0.084-4.493 0.632 0.742 0.099-5.548 0.771
 Radiographic spinal alignment
  Normal alignment 143 10 (7) Reference Reference
  Kyphosis/Scoliosis 5 1 (20) 2.760 0.348-21.841 0.336 8.749 1.069-71.643 0.043
  Subluxation/Translation 1 0 0.000 NA < 0.001 0.000 NA < 0.001
 Vertebral body fracture
  None of the below 85 5 (6) Reference
  No collapse with > 50% body involved 28 2 (7) 1.224 0.240-6.247 0.808 NA
  < 50% collapse 28 3 (11) 2.115 0.504-8.869 0.306
  > 50% collapse 8 1 (13) 2.107 0.272-16.221 0.477
 Posterolateral involvement of spinal elements
  None of the above 83 6 (7) Reference Reference
  Unilateral 44 4 (9) 1.393 0.397-4.887 0.604 0.842 0.141-5.019 0.850
  Bilateral 22 1 (5) 0.616 0.074-5.157 0.655 0.190 0.025-1.453 0.109
SINS classification
 Stability 83 6 (7) Reference
 Intermediate stability 62 4 (6) 0.964 0.275-3.371 0.954 NA
 Instability 4 1 (25) 3.491 0.414-29.456 0.251
SRS dose (Gy)
 ≤ 20 135 10 (7) Reference Reference
 > 20 14 1 (7) 1.065 0.136-9.332 0.952 1.934 0.172-21.749 0.593
ISRC sites number of treatment field
 1-3 62 5 (8) Reference Reference
 4-6 87 6 (7) 0.838 0.256-2.739 0.770 0.807 0.098-6.628 0.807
Bilsky
 Grade 0 80 5 (6) Reference Reference
 Grade 1 39 2 (5) 0.781 0.154-3.962 0.766 0.753 0.150-3.780 0.730
 Grade 2 21 3 (14) 2.733 0.635-11.767 0.177 5.368 1.129-25.530 0.035
 Grade 3 9 1 (11) 1.890 0.224-15.934 0.559 2.215 0.269-18.248 0.460

SRS, stereotactic radiosurgery; SHR, subhazard ratio; CI, confidence interval; NA, not applicable; ECOG, Eastern Cooperative Oncology Group; HCC, hepatocellular carcinoma; RCC, renal cell carcinoma; SINS, Spinal Instability Neoplastic Score; ISRC, International Spine Radiosurgery Consortium.

a)

Univariate competing-risks regressions based on Fine and Gray’s proportional subhazards model,

b)

Multivariate competing-risks regressions based on Fine and Gray’s proportional subhazards model.